Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.

Source:http://linkedlifedata.com/resource/pubmed/id/12559788

Vaccine 2003 Mar 7 21 11-12 1112-7

Download in:

View as

General Info

PMID
12559788